Switching targets to avoid resistance to CAR Ts

Overcoming resistance to traditional CAR Ts with CARs against an alternative B cell target

City of Hope researchers have engineered CAR T cells directed against a new B cell target that could overcome resistance to or replace canonical CAR Ts.

The novel CAR T therapy against TNFRSF13c, which was showcased in a

Read the full 373 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers